AAAAAA

   
Results: 1-25 | 26-30
Results: 1-25/30
STRUCTURAL AND FUNCTIONAL-RESPONSES OF MAMMALIAN THICK FILAMENTS TO ALTERATIONS IN MYOSIN REGULATORY LIGHT-CHAINS
Authors: LEVINE RJC YANG ZH EPSTEIN ND FANANAPAZIR L STULL JT SWEENEY HL
Citation: Rjc. Levine et al., STRUCTURAL AND FUNCTIONAL-RESPONSES OF MAMMALIAN THICK FILAMENTS TO ALTERATIONS IN MYOSIN REGULATORY LIGHT-CHAINS, Journal of structural biology (Print), 122(1-2), 1998, pp. 149-161
EXPRESSION OF NATURALLY-OCCURRING MUTANT HUMAN CARDIAC LIGHT-CHAINS
Authors: LIN H JIANG H POETTER K SELLERS JR EPSTEIN ND
Citation: H. Lin et al., EXPRESSION OF NATURALLY-OCCURRING MUTANT HUMAN CARDIAC LIGHT-CHAINS, Molecular biology of the cell, 8, 1997, pp. 914-914
FUNCTIONAL-ANALYSIS OF HUMAN BETA-CARDIAC MYOSIN WITH ESCHERICHIA-COLI - EXPRESSED REGULATORY LIGHT-CHAIN (RLC) MUTATIONS IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (HCM)
Authors: JIANG H LIN H WANG F EPSTEIN ND SELLERS JR
Citation: H. Jiang et al., FUNCTIONAL-ANALYSIS OF HUMAN BETA-CARDIAC MYOSIN WITH ESCHERICHIA-COLI - EXPRESSED REGULATORY LIGHT-CHAIN (RLC) MUTATIONS IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (HCM), Molecular biology of the cell, 8, 1997, pp. 915-915
THE IN-VITRO MOTILITY ACTIVITY OF BETA-CARDIAC MYOSIN DEPENDS ON THE NATURE OF THE BETA-MYOSIN HEAVY-CHAIN GENE MUTATION IN HYPERTROPHIC CARDIOMYOPATHY
Authors: CUDA G FANANAPAZIR L EPSTEIN ND SELLERS JR
Citation: G. Cuda et al., THE IN-VITRO MOTILITY ACTIVITY OF BETA-CARDIAC MYOSIN DEPENDS ON THE NATURE OF THE BETA-MYOSIN HEAVY-CHAIN GENE MUTATION IN HYPERTROPHIC CARDIOMYOPATHY, Journal of muscle research and cell motility, 18(3), 1997, pp. 275-283
DETECTION OF MUTATIONS IN THE MITOCHONDRIAL GENOME FROM MUSCLE AND LYMPHOCYTES OF PATIENTS WITH INCLUSION-BODY MYOSITIS (IBM)
Authors: SANDERS MK HASSANZEDAH S LIN H DALAKAS MC EPSTEIN ND
Citation: Mk. Sanders et al., DETECTION OF MUTATIONS IN THE MITOCHONDRIAL GENOME FROM MUSCLE AND LYMPHOCYTES OF PATIENTS WITH INCLUSION-BODY MYOSITIS (IBM), Neurology, 48(3), 1997, pp. 2102-2102
CELLULAR RECOMBINATION PATHWAYS AND VIRAL TERMINAL REPEAT HAIRPIN STRUCTURES ARE SUFFICIENT FOR ADENOASSOCIATED VIRUS INTEGRATION IN-VIVO AND IN-VITRO
Authors: YANG CC XIAO X ZHU X ANSARDI DC EPSTEIN ND FREY MR MATERA AG SAMULSKI RJ
Citation: Cc. Yang et al., CELLULAR RECOMBINATION PATHWAYS AND VIRAL TERMINAL REPEAT HAIRPIN STRUCTURES ARE SUFFICIENT FOR ADENOASSOCIATED VIRUS INTEGRATION IN-VIVO AND IN-VITRO, Journal of virology, 71(12), 1997, pp. 9231-9247
MUTATIONS IN EITHER THE ESSENTIAL OR REGULATORY LIGHT-CHAINS OF MYOSIN ARE ASSOCIATED WITH A RARE MYOPATHY IN HUMAN HEART AND SKELETAL-MUSCLE
Authors: POETTER K JIANG H HASSANZADEH S MASTER SR CHANG A DALAKAS MC RAYMENT I SELLERS JR FANANAPAZIR L EPSTEIN ND
Citation: K. Poetter et al., MUTATIONS IN EITHER THE ESSENTIAL OR REGULATORY LIGHT-CHAINS OF MYOSIN ARE ASSOCIATED WITH A RARE MYOPATHY IN HUMAN HEART AND SKELETAL-MUSCLE, Nature genetics, 13(1), 1996, pp. 63-69
INCREASED SPEED OF ACTIN MOVEMENT BY MUTANT CARDIAC MYOSIN FROM PATIENTS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY IN AN IN-VITRO MOTILITY ASSAY
Authors: JIANG H CHANG A POETTER K EPSTEIN ND FANANAPAZIR L SELLERS JR
Citation: H. Jiang et al., INCREASED SPEED OF ACTIN MOVEMENT BY MUTANT CARDIAC MYOSIN FROM PATIENTS WITH FAMILIAL HYPERTROPHIC CARDIOMYOPATHY IN AN IN-VITRO MOTILITY ASSAY, Biophysical journal, 70(2), 1996, p.
STRUCTURAL INTERPRETATION OF THE MUTATIONS IN THE BETA-CARDIAC MYOSINTHAT HAVE BEEN IMPLICATED IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY
Authors: RAYMENT I HOLDEN HM SELLERS JR FANANAPAZIR L EPSTEIN ND
Citation: I. Rayment et al., STRUCTURAL INTERPRETATION OF THE MUTATIONS IN THE BETA-CARDIAC MYOSINTHAT HAVE BEEN IMPLICATED IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY, Proceedings of the National Academy of Sciences of the United Statesof America, 92(9), 1995, pp. 3864-3868
ABNORMAL CONTRACTILE PROPERTIES OF MUSCLE-FIBERS EXPRESSING BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
Authors: LANKFORD EB EPSTEIN ND FANANAPAZIR L SWEENEY HL
Citation: Eb. Lankford et al., ABNORMAL CONTRACTILE PROPERTIES OF MUSCLE-FIBERS EXPRESSING BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY, The Journal of clinical investigation, 95(3), 1995, pp. 1409-1414
ALTERED OSCILLATORY POWER OUTPUT IN FIBERS WITH MUTATED MYOSIN FROM PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
Authors: LANKFORD EB EPSTEIN ND FANANAPAZIR L SWEENEY HL
Citation: Eb. Lankford et al., ALTERED OSCILLATORY POWER OUTPUT IN FIBERS WITH MUTATED MYOSIN FROM PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY, Circulation, 92(8), 1995, pp. 3158-3158
PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY AND LIMITATIONS OF SCREENING METHODS
Authors: FANANAPAZIR L EPSTEIN ND
Citation: L. Fananapazir et Nd. Epstein, PREVALENCE OF HYPERTROPHIC CARDIOMYOPATHY AND LIMITATIONS OF SCREENING METHODS, Circulation, 92(4), 1995, pp. 700-704
DUAL-CHAMBER PACING IS EFFECTIVE THERAPY FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH PROVOCABLE LV OUTFLOW TRACT OBSTRUCTION AND SYMPTOMSREFRACTORY TO MEDICAL THERAPY
Authors: MCAREAVEY D EPSTEIN ND FANANAPAZIR L
Citation: D. Mcareavey et al., DUAL-CHAMBER PACING IS EFFECTIVE THERAPY FOR HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH PROVOCABLE LV OUTFLOW TRACT OBSTRUCTION AND SYMPTOMSREFRACTORY TO MEDICAL THERAPY, Journal of the American College of Cardiology, 1994, pp. 10000011-10000011
RISK STRATIFICATION OF ASYMPTOMATIC PATIENTS WITH HYPERTROPIC CARDIOMYOPATHY
Authors: ATIGA WL MCAREAVEY D EPSTEIN ND FANANAPAZIR L
Citation: Wl. Atiga et al., RISK STRATIFICATION OF ASYMPTOMATIC PATIENTS WITH HYPERTROPIC CARDIOMYOPATHY, Journal of the American College of Cardiology, 1994, pp. 130000110-130000110
ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY
Authors: CUDA G FANANAPAZIR L EPSTEIN ND SELLERS JR
Citation: G. Cuda et al., ABNORMAL FUNCTION OF BETA-MYOSIN IN HYPERTROPHIC CARDIOMYOPATHY, Journal of muscle research and cell motility, 15(2), 1994, pp. 206-206
LONG-TERM RESULTS OF DUAL-CHAMBER (DDD) PACING IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - EVIDENCE FOR PROGRESSIVE SYMPTOMATIC AND HEMODYNAMIC IMPROVEMENT AND REDUCTION OF LEFT-VENTRICULAR HYPERTROPHY
Authors: FANANAPAZIR L EPSTEIN ND CURIEL RV PANZA JA TRIPODI D MCAREAVEY D
Citation: L. Fananapazir et al., LONG-TERM RESULTS OF DUAL-CHAMBER (DDD) PACING IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY - EVIDENCE FOR PROGRESSIVE SYMPTOMATIC AND HEMODYNAMIC IMPROVEMENT AND REDUCTION OF LEFT-VENTRICULAR HYPERTROPHY, Circulation, 90(6), 1994, pp. 2731-2742
IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY
Authors: FANANAPAZIR L WINKLER JB SATORIUS C EPSTEIN ND
Citation: L. Fananapazir et al., IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 442-442
MUSCLE ENERGETICS DURING DYNAMIC EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY
Authors: RYSCHON TW FOWLER MD ARAI AE WYSONG RE MCAREAVEY D EPSTEIN ND FANANAPAZIR L BALABAN RS
Citation: Tw. Ryschon et al., MUSCLE ENERGETICS DURING DYNAMIC EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 442-442
IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY
Authors: FANANAPAZIR L WINKLER JB SATORIUS C EPSTEIN ND
Citation: L. Fananapazir et al., IDENTIFICATION OF BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS IN 31 ATHLETES WITH HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 442-442
MUSCLE ENERGETICS DURING DYNAMIC EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY
Authors: RYSCHON TW FOWLER MD ARAI AE WYSONG RE MCAREAVEY D EPSTEIN ND FANANAPAZIR L BALABAN RS
Citation: Tw. Ryschon et al., MUSCLE ENERGETICS DURING DYNAMIC EXERCISE IN HYPERTROPHIC CARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 442-442
RISK-EVALUATION, THERAPY, AND PROGNOSIS IN ATHLETES WITH HYPERTROPHICCARDIOMYOPATHY
Authors: FANANAPAZIR L EPSTEIN ND
Citation: L. Fananapazir et Nd. Epstein, RISK-EVALUATION, THERAPY, AND PROGNOSIS IN ATHLETES WITH HYPERTROPHICCARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 443-443
RISK-EVALUATION, THERAPY, AND PROGNOSIS IN ATHLETES WITH HYPERTROPHICCARDIOMYOPATHY
Authors: FANANAPAZIR L EPSTEIN ND
Citation: L. Fananapazir et Nd. Epstein, RISK-EVALUATION, THERAPY, AND PROGNOSIS IN ATHLETES WITH HYPERTROPHICCARDIOMYOPATHY, Circulation, 90(4), 1994, pp. 443-443
GENOTYPE-PHENOTYPE CORRELATIONS IN HYPERTROPHIC CARDIOMYOPATHY - INSIGHTS PROVIDED BY COMPARISONS OF KINDREDS WITH DISTINCT AND IDENTICAL BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS
Authors: FANANAPAZIR L EPSTEIN ND
Citation: L. Fananapazir et Nd. Epstein, GENOTYPE-PHENOTYPE CORRELATIONS IN HYPERTROPHIC CARDIOMYOPATHY - INSIGHTS PROVIDED BY COMPARISONS OF KINDREDS WITH DISTINCT AND IDENTICAL BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS, Circulation, 89(1), 1994, pp. 22-32
ATPASE ACTIVITY AND ISOMETRIC FORCE GENERATED BY SINGLE SKELETAL MYOFIBERS IN HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS
Authors: CHAEN S HOROWITS R PODOLSKY RJ EPSTEIN ND FANANAPAZIR L
Citation: S. Chaen et al., ATPASE ACTIVITY AND ISOMETRIC FORCE GENERATED BY SINGLE SKELETAL MYOFIBERS IN HYPERTROPHIC CARDIOMYOPATHY ASSOCIATED WITH BETA-MYOSIN HEAVY-CHAIN GENE-MUTATIONS, Biophysical journal, 66(2), 1994, pp. 10000406-10000406
MISSENSE MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE CAUSE CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY
Authors: FANANAPAZIR L DALAKAS MC CYRAN F COHN G EPSTEIN ND
Citation: L. Fananapazir et al., MISSENSE MUTATIONS IN THE BETA-MYOSIN HEAVY-CHAIN GENE CAUSE CENTRAL CORE DISEASE IN HYPERTROPHIC CARDIOMYOPATHY, Proceedings of the National Academy of Sciences of the United Statesof America, 90(9), 1993, pp. 3993-3997
Risultati: 1-25 | 26-30